Alvotech (ALVO)

NASDAQ: ALVO · Real-Time Price · USD

3.290

+0.180 (5.79%)

At close: Mar 30, 2026, 4:00 PM EDT

3.210

-0.080 (-2.43%)

Pre-market: Mar 31, 2026, 8:37 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology		491.98M	93.38M	85.02M	39.68M	69.45M
Biotechnology Growth		426.84%	9.84%	114.23%	-42.86%	-16.00%
Total		491.98M	93.38M	85.02M	39.68M	69.45M
Total Growth		426.84%	9.84%	114.23%	-42.86%	-16.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Usa		273.04M	9.43M	17.94M	-	-
Usa Growth		2795.40%	-47.44%	-	-	-
Europe		157.59M	63.51M	39.43M	20.51M	19.71M
Europe Growth		148.13%	61.06%	92.27%	4.05%	-7.98%
Rest of World		59.06M	18.49M	25.66M	-	4.87M
Rest of World Growth		219.34%	-27.92%	-	-	-20.49%
North America		-	-	-	11.66M	37.93M
North America Growth		-	-	-	-69.26%	1828.22%
Asia and Other		-	-	-	4.60M	-
Asia		-	-	-	-	4.11M
Asia Growth		-	-	-	-	70.77%
Total		489.68M	91.43M	83.03M	36.77M	66.62M
Total Growth		435.56%	10.12%	125.79%	-44.80%	108.71%

Source: S&P Global Market Intelligence.